Noncanonical effector functions of the T-memory-like T-PLL cell are shaped by cooperative TCL1A and TCR signaling

S Oberbeck,A Schrader,K Warner,D Jungherz,G Crispatzu,J von Jan,M Chmielewski,A Ianevski,H H Diebner,P Mayer,A Kondo Ados,L Wahnschaffe,T Braun,T A Müller,P Wagle,A Bouska,T Neumann,S Pützer,L Varghese,N Pflug,M Thelen,J Makalowski,N Riet,H J M Göx,G Rappl,J Altmüller,M Kotrová,T Persigehl,G Hopfinger,M L Hansmann,H Schlößer,S Stilgenbauer,J Dürig,D Mougiakakos,M von Bergwelt-Baildon,I Roeder,S Hartmann,M Hallek,R Moriggl,M Brüggemann,T Aittokallio,J Iqbal,S Newrzela,H Abken,M Herling

DOI: https://doi.org/10.1182/blood.2019003348

IF: 20.3

2020-12-10

Blood

Abstract:T-cell prolymphocytic leukemia (T-PLL) is a poor-prognostic neoplasm. Differentiation stage and immune-effector functions of the underlying tumor cell are insufficiently characterized. Constitutive activation of the T-cell leukemia 1A (TCL1A) oncogene distinguishes the (pre)leukemic cell from regular postthymic T cells. We assessed activation-response patterns of the T-PLL lymphocyte and interrogated the modulatory impact by TCL1A. Immunophenotypic and gene expression profiles revealed a unique spectrum of memory-type differentiation of T-PLL with predominant central-memory stages and frequent noncanonical patterns. Virtually all T-PLL expressed a T-cell receptor (TCR) and/or CD28-coreceptor without overrepresentation of specific TCR clonotypes. The highly activated leukemic cells also revealed losses of negative-regulatory TCR coreceptors (eg, CTLA4). TCR stimulation of T-PLL cells evoked higher-than-normal cell-cycle transition and profiles of cytokine release that resembled those of normal memory T cells. More activated phenotypes and higher TCL1A correlated with inferior clinical outcomes. TCL1A was linked to the marked resistance of T-PLL to activation- and FAS-induced cell death. Enforced TCL1A enhanced phospho-activation of TCR kinases, second-messenger generation, and JAK/STAT or NFAT transcriptional responses. This reduced the input thresholds for IL-2 secretion in a sensitizer-like fashion. Mice of TCL1A-initiated protracted T-PLL development resembled such features. When equipped with epitope-defined TCRs or chimeric antigen receptors, these Lckpr-hTCL1Atg T cells gained a leukemogenic growth advantage in scenarios of receptor stimulation. Overall, we propose a model of T-PLL pathogenesis in which TCL1A enhances TCR signals and drives the accumulation of death-resistant memory-type cells that use amplified low-level stimulatory input, and whose loss of negative coregulators additionally maintains their activated state. Treatment rationales are provided by combined interception in TCR and survival signaling.

What problem does this paper attempt to address?

Noncanonical effector functions of the T-memory-like T-PLL cell are shaped by cooperative TCL1A and TCR signaling

Actionable perturbations of damage responses by TCL1/ATM and epigenetic lesions form the basis of T-PLL

High TCL1 expression and intact T-cell receptor signaling define a hyperproliferative subset of T-cell prolymphocytic leukemia

Reconstruction of rearranged T-cell receptor loci by whole genome and transcriptome sequencing gives insights into the initial steps of T-cell prolymphocytic leukemia

Advanced Pathogenetic Concepts in T-Cell Prolymphocytic Leukemia and Their Translational Impact

T-Cell Prolymphocytic Leukemia: Diagnosis, Pathogenesis, and Treatment

Morphology, immunophenotype, and suggested diagnostic criteria of TCL1 family–negative T-prolymphocytic leukemia

Noncanonical Function of AGO2 Augments T-cell Receptor Signaling in T-cell Prolymphocytic Leukemia

T cell leukemia-1 modulates TCR signal strength and IFN-gamma levels through phosphatidylinositol 3-kinase and protein kinase C pathway activation

Computational gene expression analysis reveals distinct molecular subgroups of T-cell prolymphocytic leukemia

Genes encoding members of the JAK-STAT pathway or epigenetic regulators are recurrently mutated in T-cell prolymphocytic leukaemia

Mature T-cell Leukemia Primarily Involving Blood and Bone Marrow without TCL1 or MTCP1 Rearrangement: A Subtype of T-Prolymphocytic Leukemia or a Distinct Entity?

Current understandings on T-cell prolymphocytic leukemia and its association with TCL1 proto-oncogene

Epigenetic Alteration Contributes to the Transcriptional Reprogramming in T-cell Prolymphocytic Leukemia

The TCL1 oncoprotein inhibits activation-induced cell death by impairing PKCtheta and ERK pathways

T-cell prolymphocytic leukemia: a single-institution experience

The proto-oncogene TCL1A deregulates cell cycle and genomic stability in CLL

TCL1A gene involvement in T-cell prolymphocytic leukemia in Japanese patients

Prognostic significance of cytogenetic abnormalities in T-cell prolymphocytic leukemia

TCL-1-positive hematogones in a patient with T-cell prolymphocytic leukemia after therapy

T-Cell Leukemia/Lymphoma 1 (TCL1): An Oncogene Regulating Multiple Signaling Pathways